Liraglutide
An earlier daily-dose GLP-1 receptor agonist, the first in its class approved specifically for weight management.
Research status: Long clinical track record and the longest post-market safety history among GLP-1s.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Related in Weight Loss